Yigeng Feng

Publications

354

Citations

H-Index

2016

Active since

Affiliations

Longhua Hospital Shanghai University of Traditional Chinese Medicine(Current)

Shanghai University of Traditional Chinese Medicine

Yigeng Feng is an author at Longhua Hospital Shanghai University of Traditional Chinese Medicine specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

MedicineCell BiologyTumor BiologyCancer BiologyRadiation OncologyUrologyOncologyCancer ResearchGene ExpressionSystems Biology

Publications per year

2016–2023

Publications

Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling

Chao Yu, Hongwen Cao, Xiaofeng He et al. · Biomedicine & Pharmacotherapy · 2017 · 68 citations

Cell Regulation, Dna Replication, Cell Cycle +6

Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis

Hongwen Cao, Hongjie Yu, Yigeng Feng et al. · Cancer Chemotherapy and Pharmacology · 2017 · 62 citations

Oncology, Chemoprevention Strategy, Foxd3/mir-143 Axis +10

The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4

Hongwen Cao, Renjie Gao, Chao Yu et al. · Functional & Integrative Genomics · 2019 · 59 citations

Systems Biology, Medicine, Rna-binding Protein Fxr1 +7

MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1

Lei Chen, Hongwen Cao, Yigeng Feng · World Journal of Urology · 2017 · 39 citations

Tumor Suppressor, Prostatic Disease, Cancer Paclitaxel Resistance +5

TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway

Hongwen Cao, Renjie Gao, Lei Chen et al. · FEBS Open Bio · 2020 · 24 citations · Full text

Trim66 Deficiency, Prostate Cancer Cells, Cancer Biology +16

Rows per page

1–5 of 12